ABC Family Arquivos Brasileiros de Cardiologia International Journal of Cardiovascular Sciences ABC Heart Failure & Cardiomyopathy ABC Imagem Cardiovascular
Português English
ABC Family
Português English
  • About
    • About ABC Family
    • Internal Regulation
    • Editorial Board
    • Brazilian Society of Cardiology (SBC)
  • Issues
  • SBC Guidelines
  • Content
    • Videos
    • Podcasts
    • News
  • About
    • About ABC Family
    • Internal Regulation
    • Editorial Board
    • Brazilian Society of Cardiology (SBC)
  • Issues
  • SBC Guidelines
  • Content
    • Videos
    • Podcasts
    • News

ABC Family

  • ABC Family
  • Arquivos Brasileiros de Cardiologia
  • International Journal of Cardiovascular Sciences
  • ABC Heart Failure & Cardiomyopathy
  • ABC Imagem Cardiovascular
Search in

No content found.

Journals
Ordering
Article types
Others

  1. Home
  2. Keyword: cyclosporine
Figure 1
IJCS
Original Article

Gallic Acid and Cyclosporine Mixture and their Effects on Cardiac Dysfunction Induced by Ischemia/Reperfusion and eNOS/iNOS Expression

Mohammad Badavi et al. Najmeh Sadeghi Mahin Dianat Alireza Samarbafzadeh

Abstract

Background:

Although many researches have been conducted on either a certain antioxidant or mPTP individually, little attention has been drawn to the effects of co-administration of an antioxidant and mPTP inhibitor together on cardiac dysfunction after I/R injury.

Objectives:

This study aims at determining the effects of gallic acid (as Antioxidant) combined with cyclosporine A (CsA) (as mPTP inhibitor) on I/R induced cardiac and endothelial (role of NO) dysfunction.

Methods:

Male Wistar rats were pretreated with gallic acid (7.5, 15, or 30 mg.kg-1 body weight, daily) for a period of 10 days. Then, the heart was isolated and exposed to 30-minute ischemia and perfused by CsA (0.2 µM) 20 min during reperfusion period.

Results:

The data have shown that infarct size was decreased significantly by CsA and gallic acid alone (p < 0.05, one way ANOVA followed by LSD test), however the combination of both drugs had more significant improving effects (p < 0.001). The combination of these two drugs improved more significantly maximum rate of rise and fall of ventricular pressure (±dp.dt-1 max), rate pressure product (RPP), left ventricular developed pressure (LVDP), heart rate and coronary flow rather than applying each one alone (p < 0.05, repeated measurement ANOVA followed by LSD test).

Conclusions:

In conclusion, benefiting from an antioxidant concomitant with an mPTP inhibitor could have more improving effects on the cardiac dysfunction induced by I/R injury.

  • Antioxidants
  • cyclosporine
  • Endothelium
  • Gallic Acid
  • nitric oxide Synthase
  • Rats
  • Reperfusion
  • Ventricular Function
Read Full Article
Creative Commons Attribution (CC BY) Creative Commons license
01/01/2017 DOI: 10.5935/2359-4802.20170047 Views 1
ABC
Artigo de Pesquisa

Hypolipidemic treatment under special conditions: posttransplant and/or immunosupressive therapy

Maria Cristina de Oliveira Izar

There are limited data regarding the use of hypolipidemic agents concomitantly with immunosuppressive drugs. Best evidence is provided for the use of statins and cyclosporine. In terms of pharmacodynamics, these two drugs have different substrates. In respect to pharmacokinetics, statins usually do not modify serum concentrations of cyclosporine, however when combined with any statin a careful monitoring of cyclosporine levels is recommended, due to a narrow therapeutic window of the immunosupressive agent. Conversely, cyclosporine does affect the area under the curve for many statins, by inhibiting the CYP450 3A4, thus increasing systemic exposure to statins. Pravastatin appears to be the safest compound, once it is glucuronized. The area under the curve for the other statins (simvastatin, lovastatin, atorvastatin, cerivastatin, and rosuvastatin) can be increased in variable degrees according to the site of metabolization, liver extraction by OATP-C transporter, biliary secretion, renal excretion, and drug extrusion by the MDR system.

  • cyclosporine
  • immunosuppressive therapy
  • renal transplantation
  • Statins
Read Full Article
Creative Commons Attribution (CC BY) Creative Commons license
02/01/2006 DOI: 10.1590/S0066-782X2005002400013
ABC
Artigo Original

Long-term follow-up and complications of arterial hypertension after cardiac transplantation

Luiz Aparecido Bortolotto et al. Hélio Bernardes Silva Edmar A. Bocchi Giovanni Bellotti … Noedir Stolf Adib D. Jatene

PURPOSE: To evaluate the progression of arterial hypertension (AH) and its consequences , in patients submitted to cardiac transplantation (CT) in use of cyclosporine (CY). METHODS: In 65 patients submitted to orthotopic CT, we evaluated blood pressure, serum creatinine and blood levels of CY before, 15 and 30 days, and 6, 12, 24, 48 and 60 months after CT; in 20 patients we analyzed cardiac index and systemic vascular resistance pre-CT, 15 and 30 days, 6 and 12 months after CT; in 33 patients, we studied anatomic and functional modifications by echocardiography, 24±13 months after CT. RESULTS: Thirty days after CT, AH was present in 58.5% (50% mild), and after one year, 93% of patients were hypertensives (85% moderate-to-severe), remaining unchanged during the rest of follow-up. The serum creatinine progressively increased, reaching values significantly higher than those pre-CT after one year, persisting with a mild increment until 60 months. Echocardiography showed left ventricle hypertrophy in 54% of patients, all of which had normal function. Two patients died as a direct consequence of hypertensive complications. CONCLUSION: AH in patients submitted to CT on CY use occurs early, increases in prevalence and severity during the follow-up and is mediated by an increase in vascular resistance. Also, the AH does not correlate to CY blood levels or nefrotoxicity, but it can impair renal function and compromise longevity of transplantation by inducing ventricular hypertrophy.

  • cyclosporine
  • Heart Transplantation
  • Hypertension
Read Full Article
Creative Commons Attribution (CC BY) Creative Commons license
31/01/2001 DOI: 10.1590/S0066-782X1997001100005

How to cite this article

EndNote RIS

Electronic Document Format (Vancouver)

Badavi M, Sadeghi N, Dianat M, Samarbafzadeh A. Gallic Acid and Cyclosporine Mixture and their Effects on Cardiac Dysfunction Induced by Ischemia/Reperfusion and eNOS/iNOS Expression. International Journal of Cardiovascular Sciences 2017;30(3):207-18.

Electronic Document Format (ABNT)

Badavi, Mohammad; Sadeghi, Najmeh; Dianat, Mahin; Samarbafzadeh, Alireza. Gallic Acid and Cyclosporine Mixture and their Effects on Cardiac Dysfunction Induced by Ischemia/Reperfusion and eNOS/iNOS Expression. International Journal of Cardiovascular Sciences, v. 30, n. 3, p. 207-218, Dec. 2016.

Electronic Document Format (APA)

Badavi, M., Sadeghi, N., Dianat, M., & Samarbafzadeh, A. (2017). Gallic Acid and Cyclosporine Mixture and their Effects on Cardiac Dysfunction Induced by Ischemia/Reperfusion and eNOS/iNOS Expression. International Journal of Cardiovascular Sciences, 30(3), 207-218.

Electronic Document Format (ISO)

Badavi, Mohammad and Sadeghi, Najmeh and Dianat, Mahin and Samarbafzadeh, Alireza. Gallic Acid and Cyclosporine Mixture and their Effects on Cardiac Dysfunction Induced by Ischemia/Reperfusion and eNOS/iNOS Expression. International Journal of Cardiovascular Sciences [online]. 2017, vol. 30, n. 3, [cited 2026-10-14], pp. 207-218. Available from: <https://journals.cardiol.br/en/article/gallic-acid-and-cyclosporine-mixture-and-their-effects-on-cardiac-dysfunction-induced-by-ischemia-reperfusion-and-enos-inos-expression/>. ISSN 2359-4802

EndNote RIS

Electronic Document Format (Vancouver)

Izar MCO. Hypolipidemic treatment under special conditions: posttransplant and/or immunosupressive therapy. Arquivos Brasileiros de Cardiologia 2006;85(suppl 5):50-7.

Electronic Document Format (ABNT)

Izar, Maria Cristina de Oliveira. Hypolipidemic treatment under special conditions: posttransplant and/or immunosupressive therapy. Arquivos Brasileiros de Cardiologia, v. 85, n. suppl 5, p. 50-57, Jan. 2006.

Electronic Document Format (APA)

Izar, M. C. O. (2006). Hypolipidemic treatment under special conditions: posttransplant and/or immunosupressive therapy. Arquivos Brasileiros de Cardiologia, 85(suppl 5), 50-57.

Electronic Document Format (ISO)

Izar, Maria Cristina de Oliveira. Hypolipidemic treatment under special conditions: posttransplant and/or immunosupressive therapy. Arquivos Brasileiros de Cardiologia [online]. 2006, vol. 85, n. suppl 5, [cited 2026-10-14], pp. 50-57. Available from: <https://journals.cardiol.br/article/hypolipidemic-treatment-under-special-conditions-posttransplant-and-or-immunosupressive-therapy/>. ISSN 0066-782X

EndNote RIS

Electronic Document Format (Vancouver)

Bortolotto LA, Silva HB, Bocchi EA, Bellotti G, Stolf N, Jatene AD. Long-term follow-up and complications of arterial hypertension after cardiac transplantation. Arquivos Brasileiros de Cardiologia 2001;69(5):317-21.

Electronic Document Format (ABNT)

Bortolotto, Luiz Aparecido; Silva, Hélio Bernardes; Bocchi, Edmar A.; Bellotti, Giovanni; Stolf, Noedir; Jatene, Adib D.. Long-term follow-up and complications of arterial hypertension after cardiac transplantation. Arquivos Brasileiros de Cardiologia, v. 69, n. 5, p. 317-321, Jan. 2001.

Electronic Document Format (APA)

Bortolotto, L. A., Silva, H. B., Bocchi, E. A., Bellotti, G., Stolf, N., & Jatene, A. D. (2001). Long-term follow-up and complications of arterial hypertension after cardiac transplantation. Arquivos Brasileiros de Cardiologia, 69(5), 317-321.

Electronic Document Format (ISO)

Bortolotto, Luiz Aparecido and Silva, Hélio Bernardes and Bocchi, Edmar A. and Bellotti, Giovanni and Stolf, Noedir and Jatene, Adib D.. Long-term follow-up and complications of arterial hypertension after cardiac transplantation. Arquivos Brasileiros de Cardiologia [online]. 2001, vol. 69, n. 5, [cited 2026-10-14], pp. 317-321. Available from: <https://journals.cardiol.br/en/article/long-term-follow-up-and-complications-of-arterial-hypertension-after-cardiac-transplantation/>. ISSN 0066-782X

  • About ABC Family
  • Internal Regulation
  • Editorial Board
  • Brazilian Society of Cardiology (SBC)

Issues

SBC Guidelines

  • Videos
  • Podcasts
  • News